Cancer Screening. Including any applicable lab work, for cervical, prostate, colorectal and breast (in accordance with PL 34-02, 34-03 and 34-109.
Cancer Screening. All bargaining unit members shall have access to 1 work day of leave for cancer screening concurrent with leave permitted by the City's Cancer Screening Policy. This leave will not be charged to any accrued leave. Leave may be used in half day increments. The screenings covered are: Breast, Colon, Skin, Thyroid, Oral Cavity, Lymph Nodes, Reproductive Organs and Lungs.
Cancer Screening. Effective upon City Council funding, as of June 7, 2017, all employees covered by this Agreement shall be permitted to use up to one (1) day of paid time, per calendar year, for cancer screening to run concurrent with leave permitted by the City’s Cancer Screening Policy. This leave will not be charged to any accrued leave. Leave may be used in half day increments. The screenings covered are: Breast, Colon, Skin, Thyroid, Oral Cavity, Lymph Nodes, Reproductive Organs and Lungs. Employees must have their health care provider complete the City’s Certification Form when administering the screening and employees must submit the completed form to their Department’s Personnel Officer for the benefit to be applied. Employees must comply with all notice and documentation requirements contained in the City of Boston Policy.
Cancer Screening. All employees may take up to four hours of paid leave for cancer screening, which will not be deducted from accrued leave. Physical examinations, blood work, as well as the travel time to and from these screenings, are all included in this four hour cap. Absence beyond the four hour cap must be charged to leave credits. Employees who undergo screenings outside their regular work schedules do so on their own time. Employees will coordinate any time out of the office that occurs during their normal work schedule with their supervisor and/or Department Head. Notwithstanding the preceding sentences, employee rights, if any, to take leave for any cancer-related screening will be granted consistent with and as required by applicable law.
Cancer Screening. Colorectal Cancer Screening Rates: Proportion of eligible patients who have had appropriate colorectal cancer screening. [outcome] Achieve target rate of 36.7%
Cancer Screening. Each employee is entitled to take up to four (4) hours of paid leave for one (1) annual screening for breast cancer and prostate cancer.
Cancer Screening. Each employee, including “other than full-time employees,” shall be entitled to up to four hours paid leave per calendar year for the purpose of being screened for cancer, such screening to be by a licensed medical professional and verified pursuant to such reasonable regulations regarding same as may be established by the Town from time to time.
Cancer Screening. Effective July 1, 2018, any leave taken by a member of the unit pursuant to Section 159-b of the Civil Service Law shall, to the extent required by law, be paid leave and shall not be charged to the employee’s accrued leave time (e.g., sick leave, personal leave, vacation). Employees shall use every reasonable effort to schedule such screening outside of regular work hours. Employees who take a leave of absence pursuant to Section 159-b of the Civil Service Law, as applicable, shall provide at least seventy-two (72) hours written notice of the need for such leave. Upon their return to work, the employee shall provide the District with a note from a medical professional verifying the date and time of their screening and that they received screening for breast and/or prostate cancer. Failure to do so shall result in such leave being unpaid.
Cancer Screening. Examination for cancers when there are no clinical signs the disease is present. Since screening may find diseases at an early stage, there may be a better chance of curing the disease. Examples of cancer screening tests are the mammogram (for breast cancer), colonoscopy (for colon cancer), spiral CT for lung cancer screening, oral examination for oral cancers, and the Pap test and HPV tests (for cervical cancer) (National Institute of Health, 2018).
Cancer Screening. Provider-based and Healthcare-based Barriers
